The global menopause market size was valued at USD 14.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.7% from 2021 to 2028. The high prevalence of vasomotor and other menopausal symptoms and increasing research supporting the advantages of dietary supplements is expected to drive the growth of the market.
Night sweats and hot flashes or Vasomotor Symptoms (VMS) are key symptoms of Menopausal Transition (MT). In addition, issues such as mood swings, difficulty in concentrating, and depression are also being linked to menopause. Hot flashes are experienced by around 80% of women during menopause and are characterized by transient chills, anxiety, sweating, and sensations of heat that last for around 1-5 minutes. Although hot flashes are experienced by a large number of women, other symptoms are also experienced by a considerable number, viz. weight gain, mood disorders, insomnia, night sweats, and vaginal dryness.
Menopausal Hormone Therapy (MHT), also called hormone replacement therapy and postmenopausal hormone therapy is recommended to help relieve symptoms of menopause. However, there may be adverse effects, such as vaginal bleeding, hip & vertebral fractures, dementia, urinary incontinence, breast cancer, heart attack, blood clots, stroke, and colorectal cancer. The awareness about adverse effects and risks associated with MHT might increase the adoption of supplements by menopausal women.
The COVID-19 pandemic has negatively impacted individual health. The high amount of stress and mental health problems, along with hormonal imbalance, have resulted in increasingly adverse menopausal symptoms. The pandemic and resulting lockdown restrictions have led to growing awareness about health and the role that products such as dietary supplements play in promoting health, including regulating menopausal symptoms. In August 2020, according to the results of a study conducted by the Council for Responsible Nutrition (CRN), a trade association for the functional food and dietary supplement industry, dietary supplement usage increased during the pandemic.
The dietary supplements segment dominated the menopause market and accounted for a revenue share of more than 90.0% in 2020. The segment is expected to dominate the market over the forecast period. The segment is further classified into hormonal products and non-hormonal products.
Dietary supplements are used by women to help ease the symptoms of menopause, such as hot flashes, night sweats, mood swings, and insomnia. In addition, research has shown the role of dietary supplements in the prevention of early menopause. A study published by the American Journal of Clinical Nutrition in June 2017, evaluated the effect of calcium and vitamin D from supplements and foods on women. The study revealed that a high intake of dietary calcium and vitamin D lowered the risk of early menopause.
North America dominated the market and accounted for the largest revenue share of 35.0% in 2020 owing to a high prevalence of menopausal symptoms such as hot flashes, and high healthcare expenditure. However, in Latin America, the market is expected to witness the fastest growth over the forecast period owing to key factors such as increasing awareness about women’s health.
As the millennial population is aging, the U.S. has a large number of women entering menopause; around 6,000 women are expected to enter menopause each day in the U.S. According to a menopause survey conducted by AARP, a U.S.-based nonprofit organization, for its female members between 60 years to 69 years of age around 72% of women, revealed that menopausal symptoms affected their lives and 8% of them admitted the effects to be extreme. The average age of undergoing menopause transition is early in the Latin America region, as compared to western nations. Although the prevalence of menopausal symptoms such as hot flashes is moderate in the region, the change in lifestyle and food habits is contributing to the growing adoption of dietary supplements for menopause to meet nutritional requirements.
The market is fragmented with the presence of various global and regional manufacturers. Mergers and acquisitions and expansion of product portfolios are the key strategic undertakings of these companies to increase market share. In March 2018, Teva Pharmaceuticals announced the launch of generic, Estrace Cream, for the treatment of menopausal symptoms such as vaginal and vulvar atrophy. Some of the prominent players in the menopause market include:
Bayer AG
Theramex
Teva Pharmaceutical Industries Ltd.
AbbVie, Inc.
Abbott
Pure Encapsulations, LLC.
Dr. Reddy’s Laboratories Ltd.
Report Attribute |
Details |
Market size value in 2021 |
USD 15.4 billion |
Revenue forecast in 2028 |
USD 22.7 billion |
Growth Rate |
CAGR of 5.7% from 2021 to 2028 |
Base year for estimation |
2020 |
Historical data |
2016 - 2019 |
Forecast period |
2021 - 2028 |
Quantitative units |
Revenue in USD million and CAGR from 2021 to 2028 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Treatment, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; Spain; France; Italy; Austria; Japan; China; India; South Korea; Brazil; Mexico; South Africa |
Key companies profiled |
Bayer AG; Theramex; Teva Pharmaceutical Industries Ltd.; AbbVie, Inc.; Abbott; Pure Encapsulations, LLC.; Dr. Reddy’s Laboratories Ltd. |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global menopause market report on the basis of treatment and region:
Treatment Outlook (Revenue, USD Million, 2016 - 2028)
Dietary Supplements
OTC Pharma Products
Hormonal products
Non-hormonal products
Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
U.S.
Canada
Europe
U.K.
Germany
Spain
France
Italy
Austria
Asia Pacific
Japan
China
India
South Korea
Latin America
Brazil
Mexico
Middle East & Africa (MEA)
South Africa
b. The global menopause market size was estimated at USD 14.7 billion in 2020 and is expected to reach USD 15.4 billion in 2021.
b. The global menopause market is expected to grow at a compound annual growth rate of 5.7% from 2021 to 2028 to reach USD 22.7 billion by 2028.
b. North America dominated the menopause market with a share of 35% in 2020. This is attributable to the high prevalence of menopausal symptoms such as hot flashes, and high healthcare expenditure.
b. Some key players operating in the menopause market include Bayer AG; Theramex; Teva Pharmaceutical Industries Ltd.; AbbVie, Inc.; Abbott; Pure Encapsulations, LLC.; and Dr. Reddy’s Laboratories Ltd.
b. Key factors that are driving the menopause market growth include the high prevalence of vasomotor & other menopausal symptoms and increasing research supporting the advantages of dietary supplements.
b. The dietary supplements segment dominated the menopause market and accounted for a revenue share of more than 90.0% in 2020.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.